These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 12650976

  • 1. Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders.
    Krapfenbauer K, Engidawork E, Cairns N, Fountoulakis M, Lubec G.
    Brain Res; 2003 Mar 28; 967(1-2):152-60. PubMed ID: 12650976
    [Abstract] [Full Text] [Related]

  • 2. Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome.
    Kim SH, Fountoulakis M, Cairns N, Lubec G.
    J Neural Transm Suppl; 2001 Mar 28; (61):223-35. PubMed ID: 11771746
    [Abstract] [Full Text] [Related]

  • 3. Antioxidant proteins in fetal brain: superoxide dismutase-1 (SOD-1) protein is not overexpressed in fetal Down syndrome.
    Gulesserian T, Engidawork E, Fountoulakis M, Lubec G.
    J Neural Transm Suppl; 2001 Mar 28; (61):71-84. PubMed ID: 11771762
    [Abstract] [Full Text] [Related]

  • 4. Metalloproteinase ADAMTS-1 but not ADAMTS-5 is manifold overexpressed in neurodegenerative disorders as Down syndrome, Alzheimer's and Pick's disease.
    Miguel RF, Pollak A, Lubec G.
    Brain Res Mol Brain Res; 2005 Jan 05; 133(1):1-5. PubMed ID: 15661359
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of neural cell types expressing peroxiredoxins in mouse brain.
    Jin MH, Lee YH, Kim JM, Sun HN, Moon EY, Shong MH, Kim SU, Lee SH, Lee TH, Yu DY, Lee DS.
    Neurosci Lett; 2005 Jun 24; 381(3):252-7. PubMed ID: 15896479
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human brain nucleoside diphosphate kinase activity is decreased in Alzheimer's disease and Down syndrome.
    Kim SH, Fountoulakis M, Cairns NJ, Lubec G.
    Biochem Biophys Res Commun; 2002 Aug 30; 296(4):970-5. PubMed ID: 12200143
    [Abstract] [Full Text] [Related]

  • 10. Cytoskeleton derangement in brain of patients with Down syndrome, Alzheimer's disease and Pick's disease.
    Pollak D, Cairns N, Lubec G.
    J Neural Transm Suppl; 2003 Aug 30; (67):149-58. PubMed ID: 15068247
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Peroxiredoxins in breast carcinoma.
    Karihtala P, Mäntyniemi A, Kang SW, Kinnula VL, Soini Y.
    Clin Cancer Res; 2003 Aug 15; 9(9):3418-24. PubMed ID: 12960131
    [Abstract] [Full Text] [Related]

  • 14. Aberrant protein expression of transcription factors BACH1 and ERG, both encoded on chromosome 21, in brains of patients with Down syndrome and Alzheimer's disease.
    Shim KS, Ferrando-Miguel R, Lubec G.
    J Neural Transm Suppl; 2003 Aug 15; (67):39-49. PubMed ID: 15068237
    [Abstract] [Full Text] [Related]

  • 15. Decreased brain levels of 2',3'-cyclic nucleotide-3'-phosphodiesterase in Down syndrome and Alzheimer's disease.
    Vlkolinský R, Cairns N, Fountoulakis M, Lubec G.
    Neurobiol Aging; 2001 Aug 15; 22(4):547-53. PubMed ID: 11445254
    [Abstract] [Full Text] [Related]

  • 16. Analysis of peroxiredoxin decreasing oxidative stress in hypertensive aortic smooth muscle.
    Lee CK, Kim HJ, Lee YR, So HH, Park HJ, Won KJ, Park T, Lee KY, Lee HM, Kim B.
    Biochim Biophys Acta; 2007 Jul 15; 1774(7):848-55. PubMed ID: 17556052
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differential protein expression of peroxiredoxin I and II by benzo(a)pyrene and quercetin treatment in 22Rv1 and PrEC prostate cell lines.
    Chaudhary A, Pechan T, Willett KL.
    Toxicol Appl Pharmacol; 2007 Apr 15; 220(2):197-210. PubMed ID: 17292933
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Galectin-3 down-regulates antioxidant peroxiredoxin-4 in human cardiac fibroblasts: a new pathway to induce cardiac damage.
    Ibarrola J, Arrieta V, Sádaba R, Martinez-Martinez E, Garcia-Peña A, Alvarez V, Fernández-Celis A, Gainza A, Santamaría E, Fernández-Irigoyen J, Cachofeiro V, Zalba G, Fay R, Rossignol P, López-Andrés N.
    Clin Sci (Lond); 2018 Jul 18; 132(13):1471-1485. PubMed ID: 29674526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.